An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 6, 2005, Pages 947-955

  Wilens, Timothy E ^a   Waxmonsky, James ^a   Scott, Megan ^a   Swezey, Allison ^a   Kwon, Anne ^a   Spencer, Thomas J ^a   Biederman, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DONEPEZIL;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIZZINESS; DRUG DOSE REGIMEN; DRUG TOLERABILITY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MALE; OUTCOMES RESEARCH; RATING SCALE; SIDE EFFECT; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AMPHETAMINES; ANTIMANIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDANS; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PIPERIDINES; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 29944438628     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.947     Document Type: Article

References (49)

1. Ambrosini PJ: Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 39:49-58, 2000.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington (DC), American Psychiatric Association, 1994.
3. Barkley: ADHD and the nature of self-control. New York, Guilford, 1997a.
4. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94, 1997b.
5. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit/hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446, 1996.
6. Bostic J, Biederman J, Spencer T, Wilens T, Monteaux M, Sienna M, Polisner D, Prince JB, Hatch M: Pemoline treatment of adolescents with attention-deficit/hyperactivity disorder: A ten-week controlled trial. J Child Adolesc Psychopharmacol 10:205-216, 2000.
7. Doyle A, Biederman J, Seidman L, Weber W, Faraone S: Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention-deficit/hyperactivity disorder. J Consult Clin Psychol 68:477-488, 2000.
8. DuPaul G: The ADHD rating scale: Normative data, reliability, and validity. Unpublished manuscript of the University of Massachusetts Medical School, 1990.
9. DuPaul G, Power T, Anastopoulos A, Reid R: ADHD rating scale IV: Checklists, norms, and clinical interpretation. New York, Guilford Press, 1998.
10. Faries D, Yalcin I, Harder D, Heiligenstein J: Validation of the ADHD rating scale as a clinican administered and scored instrument. J Atten Disord 5:107-115, 2001.
11. First M, Spitzer R, Gibbon M, Williams JB: Structured clinical interview for DSM-IV Axis I disorders. Washington (DC), American Psychiatric Press, 1997.
12. Fischer M: Persistence of ADHD into adulthood: It depends on whom you ask. ADHD Rep 5:8-10, 1997.
13. Gioia GA, Isquith PK, Guy SC, Kenworthy L: Behavior rating inventory of executive function. Lutz, Florida, Psychological Assessment Resources, Inc. 2000.
14. Halperin J: Conceptualizing, describing, and measuring components of attention: A summary. In: Attention, Memory, and Executive Function. Lyon G, Krasnegor N, eds. Baltimore, Paul H Brooks, 1996, pp 119-137.
15. Hardan AY, Handen BL: A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 12:237-241, 2002.
16. Hoopes SP: Donepezil for Tourette's Disorder and ADHD. J Clin Psychopharmacol 19:381-382, 1999.
17. Jones G, Sahakian B, Levy R, Warburton D, Gray J: Effects of acute subcutaneous nicotine on attention, information, and short-term memory in Alzheimer's disease, Psychopharmacology 108:485-494, 1992.
18. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and ADHD: Stimulant medicaiton and better executive function performance in children. Psychol Med 29:527-538, 1999.
19. Levin E: Nicotinic systems and cognitive function. Psychopharmaology 108:417-431, 1992.
20. Levin E, Conners C, Sparrow E, Hinton S, Erhardt D, Meek W, Rose J, March J: Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63, 1996.
21. Michelson D, Adler L, Spencer T, Reimherr FW, West S, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D: Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 53:112-120, 2003.
22. Murphy P: Cognitive functioning in adults with attention-deficit/ hyperactivity disorder. J Atten Disord 5:203-209, 2002.
23. National Institute of Mental Health: CGI (Clinical Global Impression Scale) - NIMH. Psychopharmacol Bull 21:839-844, 1985.
24. Pachaiyappan K, Petti TA, Bangs M, Pfau B, Dumlao S: Urinary incontinence with donepezil treatment in hospitalized children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 13:111-112, 2003.
25. Parrott AC, Winder G: Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: Comparative effects upon vigilance and heart rate. Psychopharmacology 97:257-261, 1989.
26. Pennington BF, Ozonoff S: Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51-87, 1996.
27. Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ: A controlled study of nortriptyline in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 10:193-204, 2000.
28. Rapport LJ, Van Voorhis A, Tzelepis A, Friedman SR: Executive function in adult attention-deficit/hyperactivity disorder. Clin Neuropsychol 15:479-491, 2001.
29. Rezvani AH, Levin ED: Cognitive effects of nicotine. Biol Psychiatry 49:258-267, 2001.
30. Rogers SL, Friedhoff LT: The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a U.S. multicenter, randomized, double-blind, placebo-controlled trial. Dementia 7:293-303, 1996.
31. Seidman LJ, Biederman J, Faraone SV, Weber W, Ouellette C: Toward defining a neuropsychology of ADHD: Performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol 65:150-160, 1997.
32. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone S: Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 44:260-268, 1998.
33. Sergeant J, Geurts H, Oosterlaan J: How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder? Behav Brain Res 130:3-28, 2002.
34. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, Doyle R, Parekh A, Kagan J, Bearman SK: Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58:775-782, 2001.
35. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attention-deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432, 1996.
36. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone S, Seidman L: Effectiveness and tolerability of tomoxetine in adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 155:693-695, 1998.
37. Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon S, Lapey K: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 52:434- 443, 1995.
38. Swanson J, McBurnett K, Christian D, Wigal T: Stimulant medications and the treatment of children with ADHD. In: Advances in Clinical Child Psychology. Ollendick T, Prinz R, eds. New York, Plenum Press, 1995, pp 265-322.
39. Tannock R: Attention-deficit/hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 39:65-99, 1998.
40. Tugal O, Yazici KM, Yagcioglu AE, Gogus A: A double-blind, placebo-controlled, crossover trial of adjunctive donepezil for cognitive impairment in schizophrenia. Int J Neuropsychopharmacol 7:117-123, 2004.
41. Walker AJ, Shores EA, Trollor JN, Lee T, Sachdev PS: Neuropsychological functioning of adults with attention-deficit/hyperactivity disorder. J Clin Exp Neuropsychol 22:115-124, 2000.
42. Wesnes K, Warburton DM: Smoking, nicotine, and human performance. Pharmacol Ther 21:189-208, 1983.
43. Wesnes K, Warburton DM: The effects of cigarettes of varying yield on rapid information processing performance. Psychopharmacology 82:338-342, 1984.
44. Wilens T, Biederman J, Prince J, Spencer T, Schleifer D, Harding M, Linehan C, Hatch M: Six-week, double blind, placebo-controlled study of desipramine for adult attention-deficit/hyperactivity disorder. Am J Psychiatry 153:1147-1153, 1996.
45. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D: A pilot-controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 156:1931-1937, 1999a.
46. Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A: Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 19:257-264, 1999b.
47. Wilens TE, Biederman J, Wong J, Spencer TJ, Prince JB: Adjunctive donepezil in attention-deficit/hyperactivity disorder youth: Case series. J Child Adolesc Psychopharmacol 10:217-222, 2000.
48. Wilens TE, Spencer T: The stimulants revisited. In: Child and Adolescent Psychiatric Clinics of North America. Stubbe C, ed. Philadelphia, Saunders, 2000, pp 573-603.
49. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A: A controlled clinical trial of bupropion for attention-deficit/hyperactivity disorder in adults. Am J Psychiatry 158:282-288, 2001.